These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8786676)

  • 1. Effects of short-term treatment with the thromboxane synthesis blocker indobufen on pressor and depressor humoral factors in healthy humans.
    Zacharieva S; Orbetzova M; Tcharaktchiev D; Angelova-Gateva P; Andonova K
    Methods Find Exp Clin Pharmacol; 1995 Nov; 17(9):615-9. PubMed ID: 8786676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen].
    Craveri A; Lanfredini M; Citella C; Braconaro F; Colombo L
    Minerva Cardioangiol; 1988 Sep; 36(9):411-8. PubMed ID: 3226570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
    Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
    Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indobufen induced modification of phospholipid composition in diabetic platelets.
    Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A
    Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.
    Rebuzzi AG; Natale A; Bianchi C; Mariello F; Coppola E; Ciabattoni G
    Eur J Clin Pharmacol; 1990; 39(1):99-100. PubMed ID: 2276396
    [No Abstract]   [Full Text] [Related]  

  • 8. Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk.
    Mannucci L; Maderna P; Colli S; Lavezzari M; Sirtori CR; Tremoli E
    Thromb Res; 1987 Nov; 48(4):417-26. PubMed ID: 3445229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
    Davì G; Patrono C; Catalano I; Custro N; Giammarresi C; Ganci A; Cosentino F; Notarbartolo A
    Arterioscler Thromb; 1993 Sep; 13(9):1346-9. PubMed ID: 8364018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood.
    Patrignani P; Volpi D; Ferrario R; Romanzini L; Di Somma M; Patrono C
    Eur J Pharmacol; 1990 Nov; 191(1):83-8. PubMed ID: 1965501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The (+)-enantiomer is responsible for the antiplatelet and anti-inflammatory activity of (+/-)-indobufen.
    Cerletti C; Manarini S; Colombo M; Tavani A
    J Pharm Pharmacol; 1990 Dec; 42(12):885-7. PubMed ID: 1983157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a single dose and short-term captopril treatment on some pressor and depressor humoral factors in healthy subjects.
    Zacharieva S; Orbetzova M; Angelova-Gateva P; Andonova K
    Prostaglandins Leukot Essent Fatty Acids; 1995 Nov; 53(5):377-80. PubMed ID: 8596778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction by indobufen of neutrophil activation in peripheral arterial occlusive disease.
    Chello M; Mastroroberto P; Celi V; Romano F; Marchese AR; Colonna A
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):417-23. PubMed ID: 8907804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism.
    Eligini S; Violi F; Banfi C; Barbieri SS; Brambilla M; Saliola M; Tremoli E; Colli S
    Cardiovasc Res; 2006 Jan; 69(1):218-26. PubMed ID: 16154551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
    Wiseman LR; Fitton A; Buckley MM
    Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.